As the days progress and we will see some unexpected matchups post at the top of the leaderboard, there’s no telling who will ...
Needham maintained a positive outlook on Cellebrite (NASDAQ:CLBT) shares by raising the price target to $28 from the previous $21, while reiterating a Buy rating. The stock, currently trading at ...